Frovatriptan succinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for frovatriptan succinate and what is the scope of patent protection?
Frovatriptan succinate
is the generic ingredient in two branded drugs marketed by Endo Pharms, Amneal Pharms Co, Glenmark Pharms Ltd, Mylan, and Renata, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for frovatriptan succinate. Five suppliers are listed for this compound.
Summary for frovatriptan succinate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 5 |
NDAs: | 5 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Patent Applications: | 243 |
What excipients (inactive ingredients) are in frovatriptan succinate? | frovatriptan succinate excipients list |
DailyMed Link: | frovatriptan succinate at DailyMed |
Pharmacology for frovatriptan succinate
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Paragraph IV (Patent) Challenges for FROVATRIPTAN SUCCINATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FROVA | Tablets | frovatriptan succinate | 2.5 mg | 021006 | 1 | 2011-03-09 |
US Patents and Regulatory Information for frovatriptan succinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renata | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 213891-001 | Apr 6, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Glenmark Pharms Ltd | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 204730-001 | Mar 11, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Mylan | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 202931-001 | Aug 28, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for frovatriptan succinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.